n(g)-iminoethylornithine has been researched along with n-(3-(aminomethyl)benzyl)acetamidine in 6 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (n-(3-(aminomethyl)benzyl)acetamidine) | Trials (n-(3-(aminomethyl)benzyl)acetamidine) | Recent Studies (post-2010) (n-(3-(aminomethyl)benzyl)acetamidine) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 328 | 1 | 106 |
| Protein | Taxonomy | n(g)-iminoethylornithine (IC50) | n-(3-(aminomethyl)benzyl)acetamidine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, brain | Homo sapiens (human) | 4.89 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 7.55 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.177 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 0.1395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Martasek, P; Masters, BS; Roman, LJ; Silverman, RB | 1 |
| László, F; Whittle, BJ | 1 |
| Li, H; Martásek, P; Masters, BS; Poulos, TL; Raman, CS | 1 |
| Nikolic, D; Silverman, RB; Van Breemen, RB; Zhu, Y | 1 |
| Alfaro, V; Genescà, M; Hotter, G; Pí, F; Sola, A; Viñas, JL | 1 |
| Gao, Y; Huo, X; Qian, SY; Sheng, S; Xu, Y; Zhou, S | 1 |
6 other study(ies) available for n(g)-iminoethylornithine and n-(3-(aminomethyl)benzyl)acetamidine
| Article | Year |
|---|---|
N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase.
Topics: Animals; Cattle; Dipeptides; Enzyme Inhibitors; Mice; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Rats | 1999 |
Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon.
Topics: Amidines; Animals; Benzylamines; Capillary Permeability; Colon; Endotoxins; Enzyme Inhibitors; Escherichia coli; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ornithine; Rats; Rats, Wistar | 1997 |
Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.
Topics: Amidines; Animals; Benzylamines; Binding, Competitive; Cattle; Crystallography, X-Ray; Enzyme Inhibitors; Ferrous Compounds; Heme; Isoenzymes; Macromolecular Substances; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Ornithine; Protein Structure, Tertiary | 2001 |
Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Topics: Amidines; Animals; Benzylamines; Biliverdine; Carbon Monoxide; Chromatography, High Pressure Liquid; Enzyme Activation; Enzyme Inhibitors; Heme; Horses; Humans; Kinetics; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ornithine; Spectrometry, Mass, Electrospray Ionization | 2005 |
NO and NOS isoforms in the development of apoptosis in renal ischemia/reperfusion.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Caspase 3; Caspases; Immunohistochemistry; Indazoles; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Ornithine; Rats; Rats, Wistar; Reperfusion Injury | 2006 |
Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.
Topics: Amidines; Antineoplastic Agents; Benzylamines; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; HT29 Cells; Humans; Neovascularization, Pathologic; Nitric Oxide Synthase; Ornithine; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing | 2019 |